| 9193729 |
Inhibiting transient receptor potential ion channel TRPA1 |
Chester A. Metcalf, III, Spencer David Kimball, Qingy Li, Blaise S. Lippa, Dominic Ryan +2 more |
2015-11-24 |
|
| 9108966 |
Beta-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Robert Busch +2 more |
2015-08-18 |
|
| 8969570 |
Beta-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Robert Busch +2 more |
2015-03-03 |
|
| 8962843 |
1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III |
2015-02-24 |
|
| 8962844 |
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III +1 more |
2015-02-24 |
|
| 8940897 |
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III |
2015-01-27 |
|
| 8933233 |
1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III |
2015-01-13 |
$44,075,000 |
| 8933232 |
1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III |
2015-01-13 |
$44,075,000 |
| 8927724 |
Isoxazole beta-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III +3 more |
2015-01-06 |
$83,951,000 |
| 8916709 |
1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors |
Yong He, Ning Yin, Dylan C. Alexander, Jason CROSS, Chester A. Metcalf, III +1 more |
2014-12-23 |
$85,149,000 |
| 8809314 |
Cephalosporin compound |
Yong He, Ning Yin, Dong Zou, Andre Lee Pearson |
2014-08-19 |
$35,066,000 |
| 8748627 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Moshe Weitzberg, Xiangdong Xu, Richard F. Clark, Tianyuan Zhang, Qun Li +5 more |
2014-06-10 |
$80,811,000 |
| 8735595 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Xiangdong Xu, Moshe Weitzberg, Hing L. Sham |
2014-05-27 |
$79,528,000 |
| 8207350 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Robert Keyes, Hing L. Sham |
2012-06-26 |
$54,448,000 |
| 8163769 |
Antibacterial compounds |
David D. Anderson, Bruce Aaron BEUTEL, Todd D. Bosse, Richard F. Clark, Curt S. Cooper +18 more |
2012-04-24 |
$29,462,000 |
| 7928243 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Richard F. Clark, Qun Li, Moshe Weitzberg, Hing L. Sham |
2011-04-19 |
$23,244,000 |
| 7737159 |
Antibacterial compounds |
David D. Anderson, Bruce Aaron BEUTEL, Curt S. Cooper, Mira Hinman, Douglas M. Kalvin +3 more |
2010-06-15 |
$56,407,000 |
| 7196200 |
Antibacterial compounds |
David D. Anderson, Bruce Aaron BEUTEL, Curt S. Cooper, Mira Hinman, Douglas M. Kalvin +3 more |
2007-03-27 |
$107,157,000 |
| 6992069 |
Tricyclic macrolide antibacterial compounds |
Zhenkun Ma, Hong Yong |
2006-01-31 |
|
| 6831096 |
Inhibitors of neuraminidases |
Clarence J. Maring, Hui-Ju Chen, Yuanwei Chen, David A. DeGoey, William J. Flosi +26 more |
2004-12-14 |
$66,667,000 |
| 6818654 |
Antibacterial compounds |
David D. Anderson, Bruce Aaron BEUTEL, Curt S. Cooper, Peter Jeffrey DANDLIKER, Caroline David +11 more |
2004-11-16 |
$53,841,000 |
| 6593314 |
Neuraminidase inhibitors |
Clarence J. Maring, Vincent L. Giranda, Stephen Hanessian, Dale J. Kempf, Darold L. Madigan +6 more |
2003-07-15 |
$53,575,000 |
| 6518305 |
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
Clarence J. Maring, Yuanwei Chen, David A. DeGoey, Vincent L. Giranda, David J. Grampovnik +15 more |
2003-02-11 |
$99,226,000 |
| 6455571 |
Inhibitors of neuraminidases |
Clarence J. Maring, Hui-Ju Chen, Yuanwei Chen, David A. DeGoey, William J. Flosi +26 more |
2002-09-24 |
$75,982,000 |
| 6030969 |
5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds |
Shripad S. Bhagwat, Richard J. Perner |
2000-02-29 |
$188,648,000 |
